McKesson and Cardinal Health Extend Distribution Agreements with CVS Health
McKesson Corporation (MCK) and Cardinal Health, Inc. (CAH) have extended their pharmaceutical distribution agreements with CVS Health (CVS), which will remain in effect through June 2032. The long-term contracts reaffirm the companies' ongoing partnership to supply pharmacy products for retail and healthcare services under the Aetna and MinuteClinic brands. Both McKesson and Cardinal Health also confirmed their fiscal year 2027 earnings guidance, signaling stability despite broader industry challenges such as inflationary pressures and shifting market dynamics. McKesson anticipates adjusted EPS between $44.20 to $44.65 (market consensus: $44.65), while Cardinal Health provided similar updated expectations. The extended agreements highlight the importance of these partnerships in maintaining supply chain efficiency for one of the largest pharmacy benefit managers and retailers in the U.S., potentially offering a buffer against market volatility.
Topics: distribution agreements EPS guidance pharmaceutical distribution